Mass spectrometry-based targeted and untargeted metabolite profiling, custom small molecule analysis and in vivo cellular respiration (Seahorse) technologies.
Our research involves the application of nutrition and nutrigenetics to the nutraceutical prevention and post-onset management of type 2 diabetes in humans, with a view to the reduction of polypharmacy.
Provides large-scale proteome identification (including PTM) and quantification analysis, targeted analysis of proteins, and has a platform setup for efficient metaproteomics analysis